international revenue
“10-K Item 1A: 'Our international revenue accounted for approximately 19%, 21% and 21% of our total revenue in each of the years ended December 31, 2025, 2024 and 2023, respectively.'”
Updated
The most significant concentration Proto Labs discloses is international revenue at 19%, classified LOW by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Proto Labs’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'Our international revenue accounted for approximately 19%, 21% and 21% of our total revenue in each of the years ended December 31, 2025, 2024 and 2023, respectively.'”
Proto Labs' disclosed concentration profile is limited to a single, modest exposure: international revenue accounted for approximately 19% of total revenue in 2025, compared with 21% in 2024 and 21% in 2023 — a low-share, structural exposure reflecting the company's geographic mix rather than dependence on any single customer, supplier, or counterparty. The trend across the three years shows international revenue holding in the low-20s percent range before easing to 19% most recently, suggesting the business remains predominantly domestic with international operations as a secondary contributor. With no customer, supplier, or single-geography concentration disclosed beyond this figure, Proto Labs' concentration risk profile reads as comparatively diversified: the one exposure on record is both low in share and structural in character, meaning it moves with global demand cycles rather than being tied to a specific counterparty relationship that could suddenly change. For an investor, this is a relatively benign type of disclosed concentration — a diversified, low-share geographic split rather than a customer, supplier, or segment dependency that could abruptly shift the business's risk profile.
For the engine’s reasoning on PRLB’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ESAB | ESAB Corporation | 2 | 0 | 1 | 3 |
| ATI | ATI Inc. | 1 | 1 | 0 | 2 |
| PRLB● | Proto Labs, Inc. | 0 | 0 | 1 | 1 |
| CMC | Commercial Metals Company | 0 | 0 | 0 | 0 |
| CRS | Carpenter Technology Corporatio | 0 | 0 | 0 | 0 |
| GPGI | GPGI, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.